Phase I/II trial of pemetrexed + carboplatin followed by maintenance pemetrexed therapy in elderly patients with advanced non-small cell lung cancer.
Phase of Trial: Phase I/II
Latest Information Update: 28 Nov 2016
At a glance
- Drugs Pemetrexed (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 09 Sep 2015 Results presented at the 16th World Conference on Lung Cancer.
- 06 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 03 Jan 2011 New trial record